118 related articles for article (PubMed ID: 2667598)
21. Dose-dependent effects of the renin inhibitor zankiren HCl after a single oral dose in mildly sodium-depleted normotensive subjects.
Ménard J; Boger RS; Moyse DM; Guyene TT; Glassman HN; Kleinert HD
Circulation; 1995 Jan; 91(2):330-8. PubMed ID: 7805235
[TBL] [Abstract][Full Text] [Related]
22. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
23. Biochemical effects of prolonged renin inhibition in marmosets.
Wood JM; Jobber RA; Baum HP; de Gasparo M; Nussberger J
J Hypertens; 1989 Aug; 7(8):615-8. PubMed ID: 2681408
[TBL] [Abstract][Full Text] [Related]
24. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.
Lely AT; Krikken JA; Bakker SJ; Boomsma F; Dullaart RP; Wolffenbuttel BH; Navis G
J Clin Endocrinol Metab; 2007 May; 92(5):1821-6. PubMed ID: 17341566
[TBL] [Abstract][Full Text] [Related]
25. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
Wong PY; Talamo RC; Williams GH; Colman RW
J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
[TBL] [Abstract][Full Text] [Related]
26. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
Zacharieva S; Koev D; Andonova K
Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
[TBL] [Abstract][Full Text] [Related]
27. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J
Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
[TBL] [Abstract][Full Text] [Related]
28. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
29. Effects of a specific and long-acting renin inhibitor in the marmoset.
Wood JM; Gulati N; Forgiarini P; Fuhrer W; Hofbauer KG
Hypertension; 1985; 7(5):797-803. PubMed ID: 3928488
[TBL] [Abstract][Full Text] [Related]
30. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone and renin inhibition by physiological levels of atrial natriuretic factor.
Brands MW; Freeman RH
Am J Physiol; 1988 Jun; 254(6 Pt 2):R1011-6. PubMed ID: 2968054
[TBL] [Abstract][Full Text] [Related]
32. An orally active inhibitor of renin.
Pals DT; Thaisrivongs S; Lawson JA; Kati WM; Turner SR; DeGraaf GL; Harris DW; Johnson GA
Hypertension; 1986 Dec; 8(12):1105-12. PubMed ID: 3539793
[TBL] [Abstract][Full Text] [Related]
33. Haemodynamic and endocrine effects of digitoxin in healthy volunteers.
Lucena MI; Moreno A; Garcia del Rio C; Bolaños MJ; Andrade R
Int J Clin Pharmacol Res; 1987; 7(2):135-40. PubMed ID: 3294618
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
Delabays A; Nussberger J; Porchet M; Waeber B; Hoyos P; Boger R; Glassman H; Kleinert HD; Luther R; Brunner HR
Hypertension; 1989 Jun; 13(6 Pt 2):941-7. PubMed ID: 2661434
[TBL] [Abstract][Full Text] [Related]
35. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
Oelkers W; Helmerhorst FM; Wuttke W; Heithecker R
Gynecol Endocrinol; 2000 Jun; 14(3):204-13. PubMed ID: 10923282
[TBL] [Abstract][Full Text] [Related]
36. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
37. Multiple ascending dose study with the new renin inhibitor VTP-27999: nephrocentric consequences of too much renin inhibition.
Balcarek J; Sevá Pessôa B; Bryson C; Azizi M; Ménard J; Garrelds IM; McGeehan G; Reeves RA; Griffith SG; Danser AH; Gregg R
Hypertension; 2014 May; 63(5):942-50. PubMed ID: 24470465
[TBL] [Abstract][Full Text] [Related]
38. Prolonged infusion of norepinephrine in the conscious dog: effects on blood pressure, heart rate, renin, angiotensin II, and aldosterone.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S114-21. PubMed ID: 6175823
[TBL] [Abstract][Full Text] [Related]
39. Rate of activation of renin-angiotensin-aldosterone axis and sodium intake in rats.
Holtzman E; Braley LM; Menachery A; Williams GH; Hollenberg NK
Am J Physiol; 1989 May; 256(5 Pt 2):H1311-5. PubMed ID: 2655479
[TBL] [Abstract][Full Text] [Related]
40. Intrarenal renin inhibition increases renal function by an angiotensin II-dependent mechanism.
Siragy HM; Lamb NE; Rose CE; Peach MJ; Carey RM
Am J Physiol; 1988 Oct; 255(4 Pt 2):F749-54. PubMed ID: 3052111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
